http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Hassam Ali,Sheena Shamoon,Nicole Leigh Bolick,Swethaa Manickam,Usama Sattar,Shiva Poola,Prashant Mudireddy 한국간담췌외과학회 2023 Annals of hepato-biliary-pancreatic surgery Vol.27 No.1
Backgrounds/Aims: Endoscopic retrograde cholangiopancreatography-guided gallbladder drainage (ERGD) is an alternative to percutaneous cholecystostomy (PTC) for hospitalized acute cholecystitis (AC) patients. Methods: We retrospectively analyzed propensity score matched (PSM) AC hospitalizations using the National Inpatient Sample database between 2016 and 2019 to compare the outcomes of ERGD and PTC. Results: After PSM, there were 3,360 AC hospitalizations, with 48.8% undergoing PTC and 51.2% undergoing ERGD. There was no difference in median length of stay between the PTC and ERGD cohorts (p = 0.110). There was a higher median hospitalization cost in the ERGD cohort, $62,562 (interquartile range [IQR] $40,707–97,978) compared to PTC, $40,413 (IQR $25,244–65,608; p < 0.001). The 30-day inpatient mortality was significantly lower in hospitalizations with ERGD compared to PTC (adjusted hazard ratio 0.16, 95% confidence interval [CI]: 0.1–0.41; p < 0.001). There was no difference in association with blood transfusions, acute renal failure, ileus, small bowel obstruction, and open cholecystectomy conversion (p > 0.05) between hospitalizations with ERGD and PTC. There was lower association of acute hypoxic respiratory failure (adjusted ratio [AOR] 0.46, 95% CI: 0.29–0.72; p = 0.001), hypovolemia (AOR 0.66, 95% CI: 0.49–0.82; p = 0.009) and higher association of lower gastrointestinal bleed (AOR 1.94, 95% CI: 1.48–2.54; p < 0.001) with ERGD compared to PTC. Conclusions: ERGD is a safer alternative to PTC in patients with AC. The risk complications are lower in ERGD compared to PTC but no difference exists based on mortality or conversion to open cholecystectomy.
Exercising agency: A Bourdieusian account of Iranian feminist translators
Jalalian Daghigh Ali,Jan Jariah Mohd,Kaur Sheena 이화여자대학교 아시아여성학센터 2022 Asian Journal of Women's Studies(AJWS) Vol.28 No.1
In spite of the challenges imposed on practices of feminist cultural production in restrictive states, feminist activists have contributed to speaking about the needs of women through their writings and translations. While earlier studies have highlighted the role of translators in communicating external feminist ideas, factors that have contributed to their agency remain unexplored. The present study, framed by Bourdieu’s theory, is an attempt to address this gap by locating the social, cultural, and economic capital of Iranian feminist translators within the conservative publication context of Iran. In doing so, in-depth semi-structured interviews were conducted with 17 Iranian translators of feminist works. Our findings show that despite the regulatory measures imposed on cultural production, translators have managed to compete against the doxa of the publishing sphere and produce heterodoxa by publishing translations of secular feminist works.
Toshihiro Takami,Nobuyuki Shimokawa,Jutty Parthiban,Mehmet Zileli,Sheena Ali 대한척추신경외과학회 2020 Neurospine Vol.17 No.4
This is a review article examining the pharmacologic and regenerative cell therapy for spinal cord injury. A literature search during last 10 years were conducted using key words. Case reports, experimental (nonhuman) studies, papers other than English language were excluded. Up-to-date information on the pharmacologic and regenerative cell therapy for spinal cord injury was reviewed and statements were produced to reach a consensus in 2 separate consensus meeting of WFNS Spine Committee. The statements were voted and reached a consensus using Delphi method. Pharmacologic and regenerative cell therapy for spinal cord injury have long been an interest of many experimental and clinical researches. Clinical studies with methylpredinisolone have not shown clear cut benefit. Other drugs such as Rho inhibitor, minocycline, riluzole, granulocyte colony-stimulating factor have also been tried without significant benefits. Regenerative cell therapy using different types of stem cells, different inoculation techniques, and scaffolds have undergone many trials highlighting the efficacies of cells and their limitations. This review article summarizes the current knowledge on pharmacologic and regenerative cell therapy for spinal cord injury. Unfortunately, there is a need for further experimental and human trials to recommend effective pharmacologic and regenerative cell therapy.